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Abstract During the onset of a disease a cell may experience alterations in both the composition
and organization of its cellular and molecular structures. These alterations may eventually lead to
changes in its geometrical and mechanical properties such as cell size and shape, deformability and
adhesion. As such, knowing how diseased cells respond to mechanical forces can reveal ways by
which they diﬀer from healthy ones. Here, we will present biomechanistic insights into red blood cell
related diseases that manifest mechanical property changes and how they directly contribute to the
pathophysiology of diseases. By conducting cell and molecular mechanics studies, not only can we
elucidate changes in the structure-property-function relationship of diseased cells, we can also exploit
the new knowledge gained to develop biomechanics based devices that may better detect and diagnose
these diseases as well as help identify important biomechanical targets for possible therapeutic inter-
ventions. c© 2011 The Chinese Society of Theoretical and Applied Mechanics. [doi:10.1063/2.1101400]
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I. INTRODUCTION
Human diseases are known to threaten our health
and well-being by causing impairment or damage to our
bodily structures and functions. Such impairment can
occur not only to organs and tissues, but also to cells
and proteins. Cells, being the basic functional units
of our human body, are especially of great interest as
they can yield important and critical insights into the
etiology of diseases. In fact, some diseases are known
to give rise to, or arise from, changes in the mechani-
cal and structural properties of cells.[1–4] Such altered
mechanical properties of living cells are a characteris-
tic feature of several important human diseases such as
malaria, sickle cell anemia and cancer.[1–4] Also, abnor-
mal mechanical properties of a cell have been known to
interfere with its normal physiological functions which
then directly result in the pathophysiology of diseases.
Studies have indicated that there are several possi-
ble physical or mechanistic changes arising from some
diseases. These include changes in cell size and shape
(e.g. malaria, sickle cell anemia, spherocytosis), de-
formability (e.g. malaria, cancer, sickle cell anemia) and
cell adhesion (e.g. malaria, cancer).[1–4] Such changes in
the geometrical and mechanical properties are often in-
dicative of changes occurring in the molecular composi-
tion and organization of the cell. As these changes occur
at the micro and nano scale, state-of-the-art micro- and
nanotechnological tools are needed to probe changes in
the micro- and nanometer and nano- and piconewton
scales. These tools include laser traps, optical stretch-
ers, magnetic tweezers, atomic force microscopes, mag-
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netic twisting cytometers, cytoindenters, microplate
manipulators and microﬂuidics among others.[5,6] These
are now routinely being used as research tools in the
laboratory to physically and quantitatively probe the
states of both healthy and diseased cells.
Here, we will present biomechanistic insights into
the pathology of red blood cell (RBC) related dis-
eases by examining changes in the structure–mechanical
property–function relationship of RBCs in both health
and disease. Arising from these insights, we hope to
obtain better understanding of human diseases, exploit
such new knowledge to develop biomechanics based de-
tection and diagnostic devices to better assess the onset
or progression of diseases, and achieve breakthroughs
through identifying potential biomechanical targets for
therapeutic interventions.
II. ALTERED RED CELL MECHANICS AND
PATHOLOGICAL OUTCOMES
A. Structure of Healthy Red Blood Cell
The RBC has a unique ability to undergo repeated
large deformation as it traverses through blood ves-
sels and microcapillaries as small as 2-3μm in diam-
eter in its lifespan of about 120 days. The membrane
of RBCs primarily consists of a phospholipid bi-layer
with an underlying two-dimensional network of spectrin
molecules. This composite membrane structure gives
the RBC its discocyte shape and the membrane its elas-
tic and biorheological properties.[7] The bi-layer mainly
contributes to bending resistance and maintains the cell
surface area while the spectrin network possesses shear
elastic properties. There are also integral membrane
proteins that connect the bi-layer to the spectrin net-
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Fig. 1. (a) Stretching of healthy (H-RBC) and P. falciparum schizont stage infected RBCs (Pf-S-pRBC) at diﬀerent forces
using optical tweezers.[4] Note the stiﬀer and almost rigid late schizont stage infected RBC; (b) mechanical trapping of
infected and healthy RBCs at diﬀerent depths of microﬂuidic wedges;[12] (c) rolling of infected RBCs on ICAM-1 coated
surface in a microﬂuidic ﬂow channel mimicking physiological ﬂow condition.[13]
work. Disruptions or perturbations to the membrane
via the bilipid layer, spectrin network and/or mem-
brane proteins are known to change cell morphology
and deformability.[8] In fact, the altered RBC mem-
brane mechanics are known to be directly related to
several RBC related diseases or disorders which we will
now discuss in more detail.
B. Malaria
Malaria is currently one of the world’s most health-
threatening diseases, infecting about 500 million peo-
ple and resulting in more than 1 million deaths each
year.[9] Malaria is a perfect disease model for biome-
chanics studies as the malarial infected RBCs manifest
all three physical and mechanistic changes in cell geom-
etry, deformability and adhesion. Malaria infection is
caused by a single cell parasite of the genome of Plas-
modium. Human malaria infection involves four species,
in which Plasmodium falciparum (P. falciparum) is
of upmost importance because of its severity and fa-
tality due partly to its unique sequestration related
mechanopathology. When invaded by the malarial par-
asite merozoite, RBCs undergo extensive structural and
molecular changes during a 48-hour intra-erythrocytic
cycle which result in the infected RBCs becoming stiﬀer
and more adhesive to the endothelium.
One of the survival strategies of the parasite is to
prevent itself and the stiﬀened host RBCs from being
cleared by the spleen. It does this by exporting en-
dothelium binding proteins to the RBC membrane so
as to promote adhesion between the infected RBCs and
the endothelium lining the blood vessel walls. The ex-
ported proteins literally interact and embed themselves
in the spectrin network, thus modifying the membrane
surface and stiﬀening the RBC membrane signiﬁcantly.
As a result of P. falciparum infection, the infected RBCs
adhere and accumulate in the microvasculature of a va-
riety of diﬀerent organs,[10] a phenomenon termed se-
questration. For the human host, the sequestration and
resultant accumulated infected RBCs in the capillaries
are clearly detrimental in triggering overwhelming in-
nate immunological responses and perturbing and even
blocking microcirculatory blood ﬂow. This eventually
leads to tissue dysfunction and organ failure.
To better understand mechanical property changes
associated with P. falciparum infection and their con-
tributions to the pathology of the disease, several in
vitro experiments and computational studies have been
conducted to probe either cell-population or single-cell
biomechanics. Among the experimental techniques, mi-
cropipette aspiration, optical traps, atomic force mi-
croscopy and microﬂuidics have been employed to mea-
sure the eﬀects of P. falciparum parasites on the de-
formability and cytoadherence of human RBCs with res-
olutions of force and displacement down to piconewton
and nanometer scale, respectively.[1,2,11]
014000-3 Mechanopathology of red blood cell diseases Theor. Appl. Mech. Lett. 1, 014000 (2011)
Fig. 2. (a) Surface imaging of a P. falciparum infected RBC using atomic force microscopy; (b) illustration of single molecule
binding force measurement of ligand-receptor interactions involved in cytoadherence of a malaria infected RBC.[20] Here,
the schematic shows diﬀerent stages of a force–displacement curve when an AFM tip functionalized with binding receptors
ﬁrst approaches (A), contacts (B), retracts (C) and ﬁnally detaches (D) from a cell surface.
Optical tweezers have been used to conduct uniax-
ial stretching of malaria infected RBCs to quantify the
increased stiﬀness of the cell. Here, a small stretching
force ranging from tens to hundreds of piconewton was
applied to stretch the both healthy and malaria-infected
RBCs (Fig. 1(a)).[4] Cell membrane stiﬀness was found
to increase up to about nine times that of its healthy
counterparts. Also, together with genetic manipulation
techniques, we are now able to explore the contribution
of parasite exported proteins to mechanical property
changes of membrane by speciﬁc gene knock-out/knock-
down and knock-in methods. A few targets have
been identiﬁed, including RESA[14] responsible for early
stage stiﬀness changes and KAHRP,[15] PfEMP3[15] and
Pf332[16] for late stage stiﬀness changes. Such changes
are induced possibly at the cytoskeleton level, through
interaction and cross-linking of host spectrin network
by parasite exported proteins.[17,18]
A pioneering microﬂuidic experiment, using small
microchannels mimicking narrow capillaries, demon-
strated that stiﬀer infected RBC cells irreversibly block
the passage of normal RBCs through the channel.[19]
A recent high-throughput microﬂuidic screening study
further demonstrated the deformability limits of both
normal and infected RBCs of diﬀerent stages using ar-
rays of microchannels constriction with precisely engi-
neered dimensions (Fig. 1(b)).[12]
Besides reduced deformability, P. falciparum in-
fected cells also experience another mechanopatholog-
ical change: cytoadherence or adhesion to the endothe-
lial cells and other healthy and infected cells. It has
been shown that after about 24 hours of post inva-
sion, the membrane of P. falciparum-infected RBCs be-
comes decorated with electron dense knob-like protru-
sions which have the dimensions of 50–100 nm in diam-
eter and 10–20 nm in height and increase in size and
number as the parasite matures(Fig. 2(a)).[21,22] These
knobs comprise parasite proteins embedded between the
RBC spectrin network and lipid membrane and play a
key role in mediating cytoadherence.[12,15,23–25] Classi-
cal static binding assay, biochemical and genetic meth-
ods have provided insights into the identities of the
molecules of both infected RBC and endothelial cell sur-
faces involved in cytoadherence.[26]
Since cytoadherence occurs in circulation, dynamics
of the molecular interactions arising from cell adhesion
in a high shear ﬂow environment needs to be carefully
studied. One of the pioneering approaches to study the
dynamics of cytoadherence is ﬂow adhesion assays,[27]
which mimics the physiologically relevant shear ﬂow
conditions that the cytoadherent infected RBCs would
have experienced in vivo. Further improvement based
on previous investigation is microﬂuidic based ﬂow as-
says where the size of the channels is reduced to mimic
the dimensions of microcapillaries where most of the
cytoadherent infected cells reside (Fig. 1(c)). [13,28] Al-
though ﬂow assays have provided signiﬁcant informa-
tion on the cell adhesion behavior under hydrodynamic
conditions, a population of cells is involved and this cre-
ates a limitation in the quantitative study of cytoadher-
ence at the single cell and single molecule level. To gain
a deeper understanding of the dynamic adhesion of spe-
ciﬁc cytoadherent ligands/receptor pairs at the single
molecule level, atomic force microscopy (AFM) based
single molecule force spectroscopy, can be employed to
quantitatively probe the interaction force and deduce
binding kinetics of the single parasite ligand with the
endothelial cell surface receptors (Fig. 2(b)).[29]
In terms of computational studies, several groups
have attempted to model the single cell mechanics as
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Fig. 3. (a) Numerical modeling of the deformation of multiple RBCs arising from ﬂuid-RBC interactions in a capillary ﬂow
using the immersed boundary method. RBC membrane was modeled using hyperelastic thin shell. Top picture shows ten
RBCs initially distributed symmetrically in ﬂow and bottom picture shows RBCs deformed symmetrically and parachute
shapes were formed at a later stage;[30] (b) ﬁnite element model detailing the 3D biconcave geometry of the human RBC.
The RBC membrane structure which consists of the phospholipid bi-layer, spectrin network and transmembrane proteins
were modeled with a hyperelastic continuum material. The rigid silica beads which acted as “handlers” for RBC stretching
were assumed to be attached to the cell over a small oval region;[31] (c) numerical modeling of hemodynamics arising from
malaria infection. The RBC membrane was modeled with a spring network of particles with tunable spring constants to
represent both healthy and infected RBCs. A malaria parasite within the IRBC was modeled as a rigid object.[32]
well as the hemodynamics of both healthy and malaria
infected RBCs.[3,30] The methods include the immersed
boundary method to model healthy RBC–ﬂuid inter-
action in a capillary (Fig. 3(a)),[30] the ﬁnite element
method to model the laser tweezers stretching of sin-
gle RBCs (Fig. 3(b))[31] and the 2D spring network of
particles with tunable spring constants to model the
membranes of both healthy and malaria infected RBCs
(Fig. 3(c)).[32] These computational studies will cer-
tainly contribute towards better understanding of the
mechanisms that leads to stiﬀening of the infected RBC
as well as the change in hemodynamics arising from the
presence of stiﬀer infected RBCs in circulation.
The biomechanistic insights from these single-
molecule, single-cell and cell population studies not only
help to reveal biophysical property changes associated
with disease progression, but also provide a plausible
novel platform for disease diagnosis and therapeutic in-
terventions. For example, based on the deformability
diﬀerence between the diseased and normal RBCs, a
simple margination based microﬂuidic cell sorting sys-
tem can be developed to eﬀectively detect and iso-
late malaria infected cells from healthy cells for fur-
ther studies.[33] Another example is that of the single
molecule force spectroscopy study of the binding kinet-
ics involved in cytoadherence or cell adhesion. Such
in-depth study will be useful in identifying targets for
the development of anti-cytoadherent drugs in order to
reduce or eliminate the virulence of the disease.[34,35]
C. Sickle Cell Anemia
Sickle cell anemia is a hereditary blood disorder
where changes in the molecular structure of hemoglobin
result in stiﬀer sickle or crescent shaped RBCs. As
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these stiﬀer sickle-shaped RBCs have diﬃculty travers-
ing through small capillaries in the body, this gives rise
to circulation problems and deprives tissues and organs
of oxygenated blood. Also, these stiﬀer diseased RBCs
are easily cleared from circulation by the spleen. Cell
mechanics studies have been performed to probe me-
chanical property changes of sickle-shaped RBCs us-
ing optical tweezers and micropipette aspiration.[36–39]
Studies showed that RBCs from sickle cell anemia pa-
tients were stiﬀer and more viscous as compared with
healthy RBCs. As a result, these stiﬀer sickle-shaped
RBCs tend to clog blood vessels and capillaries leading
to anemia.
D. Other Red Blood Cell Disorders
One of the most common hereditary RBC disorders
is spherocytosis. It involves disorder in the RBC mem-
brane and results in spherical RBCs with reduced diam-
eter and much higher hemoglobin content.[40,41] Sphe-
rocytosis is caused by defects in the proteins that con-
nect the spectrin network to the bilipid layer. Here, the
decreased spectrin density results in reduced spectrin
connectivity which then leads to membrane mechanical
instability and even loss of bilipid layer and membrane.
As the loss in RBC surface area is much more rapid than
its loss of volume, spherical RBCs exhibiting decreased
deformability are then formed. Research has been done
to measure the Deformability Index via ektacytometer
measurements of the healthy and spherical RBCs as a
function of spectrin concentration. Results indicated
that the lower spectrin density led to smaller values of
Deformability Index.[42]
Another hereditary RBC membrane disorder is el-
liptocytosis which gives rise to elliptical, oval or elon-
gated RBCs. Most elliptocytosis cases involve disrup-
tions of the self-association of spectrin tetramers into
the spectrin network.[43] Thus, as the spectrin network
formation is impaired, the membrane mechanical stabil-
ity is adversely aﬀected and the deformability is greatly
reduced. One outcome of these defective stiﬀer RBCs is
the easy clearance from circulation by the spleen. Thus,
these diseased RBCs have a shorter lifespan as com-
pared to healthy RBCs due to their lower membrane
deformability and compromised membrane mechanical
stability.
III. CONCLUSION & OUTLOOK
The biomechanics approaches to studying human
diseases are now yielding important insights into how
the altered mechanical properties of cells can lead to
pathophysiological outcomes. Such ﬁndings are impor-
tant for several reasons. Firstly, the altered cellular me-
chanical properties can potentially act as biomarkers in
the detection and diagnosis of diseases. Secondly, one
can now develop new biomechanics-based assays and
diagnostic devices that can be highly sensitive in the
early detection of mechanically altered diseased cells as
an indication of disease onset or progression. Thirdly,
one can potentially develop drugs to prevent or inhibit
pathological outcomes by tuning the mechanical prop-
erties of diseased cells closer to that of its healthy coun-
terparts, once the biomechanical targets for therapeutic
intervention are known.
However, to advocate a much broader impact and
clinical use of such human disease mechanics research,
there are two major limitations that one needs to over-
come. One is that the current experimental techniques
employed in the laboratory to test diseased cells are still
very laborious and time consuming. We will need to
develop faster and more high-throughput methods that
can yield suﬃcient statistical data for accurate analy-
sis. Another limitation is in not being able to easily
and quickly extract the sometimes rare individual dis-
eased cells from blood or tissue samples obtained from
patients. To address these limitations eﬃcient cell sep-
aration, an essential ﬁrst step in many biological and
biomedical assays, is needed. Recently, numerous state-
of-the-art microﬂuidics based cell separation techniques
have been developed.[44] These microﬂuidics based tech-
nologies have the potential to integrate and automate
all the necessary processes - from sample preparation
to testing of diseased cells — and will allow for rapid,
high-throughput, sensitive and eﬀective analysis of dis-
eases. Finally, we hope this eﬀort will eventually re-
sult in the better understanding of diseases and lead to
better means of detecting the onset or progression of
diseases as well as development of better treatments.
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